Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

The Potential Role of Mitochondria in the Microbiota-Gut-Brain Axis: Implications for Brain Health
Lei Qiao, Ge Yang, Peng Wang, et al.
Pharmacological Research (2024) Vol. 209, pp. 107434-107434
Open Access | Times Cited: 10
Relationship between enriched environment and neurodegeneration: a review from mechanism to therapy
Yang Xu, YangQuan Chen, Jia‐xin Xing, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer’s disease mice
Min Liu, Jirong Pan, Xiaomeng Li, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Neuroprotective role of Epigallocatechin-3-Gallate, Albeginin and Melanoxetin in Alzheimer's Disease
Arif Malik, Mehreen Hassan, Sulayman Waquar, et al.
Phytomedicine Plus (2025), pp. 100740-100740
Open Access
Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer's disease
Qiyao Zhang, Yuting Li, Qunhua Jin, et al.
Chinese Chemical Letters (2025), pp. 110964-110964
Closed Access
Clinical Aspects of Mental Imagery in Alzheimer’s Disease-Related Dementia: A Review of Cognitive, Motor, and Emotional Interventions
Αnna Christakou, Marousa Pavlou, George Stranjalis, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 223-223
Open Access
Systemic aging and aging‐related diseases
Qiao Li, Nanyin Xiao, Heng Zhang, et al.
The FASEB Journal (2025) Vol. 39, Iss. 5
Open Access
Modulating lipid droplet dynamics in neurodegeneration: an emerging area of molecular pharmacology
RS Verma, Prateek Sharma, Veerta Sharma, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Silicon Incorporated Tacrine: Design, Synthesis, and Evaluation of Biological and Pharmacokinetic Parameters
Akshay S. Kulkarni, Sreenivasa Rao Ramana, Vijay K. Nuthakki, et al.
RSC Medicinal Chemistry (2025)
Closed Access
The global, regional, and national burdens of dementia in 204 countries and territories from 1990 to 2021: A trend analysis based on the Global Burden of Disease Study 2021
Sophia Zhong, Chao Xiao, Rida Li, et al.
Medicine (2025) Vol. 104, Iss. 11, pp. e41836-e41836
Open Access
Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
Guannan Zhu, Hong Zhang, Ruoxi Xie, et al.
Advanced Healthcare Materials (2025)
Closed Access
From genes to drugs: targeting Alzheimer’s with circadian insights
Zekun Li, Xiaohan Li, Lei Su, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Alzheimer’s Disease: Recent Developments in Pathogenesis, Diagnosis, and Therapy
Ivana Shawkatová, Juraj Javor
Life (2025) Vol. 15, Iss. 4, pp. 549-549
Open Access
Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine
Marie Karam, Alba Ortega-Gascó, Daniel Tornero
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3275-3275
Open Access
Ferroptosis and Alzheimer’s: unveiling new avenues for the treatment and prevention
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Analysis of human brain RNA-seq data reveals combined effects of 4 types of RNA modifications and 18 types of programmed cell death on Alzheimer’s disease
Ke Ye, Xinyu Han, Maoyi Tian, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Bibliometric and Visual Analysis of Alzheimer’s Disease and Herpes Simplex Virus Type 1 Infection Between 1990 and 2024
Hongling Ren, Ruiyao Song, Hairong Wang, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 2097-2109
Open Access
Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer’s disease
Haoyang Wang, Junying Pan, Mingming Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Biological Effects of Dietary Restriction on Alzheimer's Disease: Experimental and Clinical Investigations
Zijiao Liu, Jun Zhang, Jiang Fei, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access
Identification of novel ligands against GSK-3β: Molecular Docking, ADMET filtering, MD Simulations, MM-GBSA studies, and DFT analysis
Nachiket Joshi, Rajasekhar Reddy Alavala
Computational Biology and Chemistry (2025), pp. 108478-108478
Closed Access
GPR75: Advances, Challenges in Deorphanization, and Potential as a Novel Drug Target for Disease Treatment
Jingyi Han, Jiaojiao Li, Siu‐Long Yao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4084-4084
Open Access
Structural characterization of Hericium coralloides polysaccharide and its neuroprotective function in Alzheimer's disease
Yue Guan, Chunyue Wang, Lanzhou Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 133865-133865
Closed Access | Times Cited: 3
Association of white matter hyperintensities with cognitive decline and neurodegeneration
Taoran Li, Bai-Le Li, Xinran Xu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Advances in the structural modification of Alzheimer’s disease drug – Huperzine A
Xiaoxin Zhu, Jin‐Bu Xu, Feng Gao, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108012-108012
Closed Access
Page 1

Scroll to top